Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Single-arm Clinical Trial Evaluating the Safety and Efficacy of the Pulse Field Ablation System in Combination With the Pulse Field Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation.

NCT06039722 is registered in ClinicalTrials.gov with Shenzhen Pulsecare Medical Technology Co., Ltd. as lead sponsor.

NCT NCT06039722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06039722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Single-arm Clinical Trial Evaluating the Safety and Efficacy of the Pulse Field Ablation System in Combination With the Pulse Field Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation.
Lead sponsor
Shenzhen Pulsecare Medical Technology Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
November 3, 2022
Completion date
August 29, 2024
Enrollment
166 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation